← FDA DRUG APPROVALS

FDA ANDA · ANDA060569

GRISEOFULVIN MICROSIZE

griseofulvin

Sponsor: CHARTWELL RX

APPLICATION
ANDA060569
TYPE
ANDA
ORIGINAL APPROVAL
1971-09-09
LATEST ACTION
2001-01-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FULVICIN-U/FPrescription
GRISEOFULVIN, MICROSIZE 500MG · TABLET · ORAL
FULVICIN-U/FPrescription
GRISEOFULVIN, MICROSIZE 250MG · TABLET · ORAL

Approval history

2001-01-26Manufacturing (CMC) · Supplement 7AP
1971-09-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →